Initial clinical trials with allogeneic myoblast injection into the muscles of non-immunosuppressed DMD patients showed only a transient restoration of dystrophin-positive fibers and limited improvements in muscle strength because of a rapid cell death and immune rejection of the injected cells [33–38]. Here, DMD is linked to Duchenne muscular dystrophy.